Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

Avicenna PPI TF Position Paper

Avicenna PPI TF Position Paper

BACK

Avicenna PPI TF Position Paper

The "Nothing about us without us" principle is often overlooked in biomedical research and innovation. Technologists traditionally try to innovate without involving the very people they aim to help, thereby overlooking the opportunity to tailor project outcomes to the beneficiaries’ specific needs through early involvement, such as, Public and Patient Involvement (PPI).

PPI can bring patient relevance, foster technology adoption, reduce costs, and accelerate research translation. The Avicenna Alliance (AA) has established a PPI task force to address the lack of PPI for in silico medicine. While PPI has gained momentum in the wider biomedical community, AA members have shown low awareness and limited support for implementing PPI. The task force aims to create awareness, support implementation, and enable a culture change within the in silico medicine community to maximise societal impact together with patients and the public. This position paper shall serve as a beacon for establishing the PPI task force within the AA and beyond.

Link to the publication


NEWS

News Avicenna Alliance publishes the 5th Release of its In Silico Glossary

Avicenna Alliance publishes the 5th Release of its In Silico Glossary

The Avicenna Alliance ispleased to announce the publication of the 5th Release of the Avicenna …

News Computational Modeling and Simulation of Medical Devices - Book Release

Computational Modeling and Simulation of Medical Devices - Book Release

The medical device industry is increasingly adopting computational modeling and simulation (CM&S) throughout the product life cycle—from early-stage design and prototyping to regulatory submissions and post-market performance evaluation. A key challenge across all these applications is establishing whether a model is sufficiently credible to support (regulatory) decision-making. The ASME V&V 40 standard, published in 2018, introduced a risk-based framework for assessing model credibility and has gained broad acceptance across the industry.

News BSI Joins the Avicenna Alliance to Advance Trust in In Silico Medicine

BSI Joins the Avicenna Alliance to Advance Trust in In Silico Medicine

The Avicenna Alliance is delighted to welcome the British Standards Institution (BSI) – …

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2026 Avicenna Alliance | powered by We Berry